.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Lab21 and ITOR Unveil Major Leap Forward in Personalized Cancer Medicine

March 7, 2012

The new Lab21 Clinical Genomics Center at ITOR will allow cancer patients to benefit from new technology to receive real-time feedback and treatment plans tied to their cancer's specific DNA signature. Greenville Hospital System University Medical Center will be one of the first sites in the country to bring Ion Torrent next-generation gene-sequencing technology into a clinical environment for personalized oncology medicine studies.

Joe Stephenson

"Bringing this leading-edge technology to the cancer clinic represents a significant breakthrough and the culmination of a seven-year journey," said Dr. , medical director for GHS' Institute for Translational Oncology Research. "This genomics center is another major step towards fulfilling our vision to provide personalized cancer care — better enabling us to offer the right drug, at the right time, to the right patient."

Read the full story: http://hcp.lv/AlKgxQ

Source: bizjournals.com/PR Newswire